Giovanni Frisoni

Giovanni Frisoni

Nom du groupe: Laboratory of Neuroimaging of Aging

Affiliations: Faculty of Medicine, Geneva University Hospitals, Department of Psychiatry

Domaines: Development and Plasticity

Mot clés: Alzheimer's disease, biomarkers, health care

Activités de recherche

The group has over 20 years of experience in clinical and translational research on Alzheimer’s disease. The main scientific interest is the use of neuroimaging techniques and other biomarkers in persons with or at risk for cognitive impairment. Acquisitions and innovations in fundamental neurosciences, ICT, and technology are uptaken and translated for use into a clinical setting for better pathophysiological understanding, diagnosis, prognosis, disease tracking, drug therapy, and rehabilitation. Specific topics of investigation are: the clinical use of imaging and fluid biomarkers; in vivo neurobiology of Alzheimer’s disease; the clinical use of innovative PET ligands; harmonisation of imaging markers for clinical use; development of innovative image analysis environments based on advanced ICT technology.

Dernières publications

Amyloid-PET imaging predicts functional decline in clinically normal individuals.

Quenon L , Collij LE , Garcia DV , Lopes Alves I , Gérard T , Malotaux V , Huyghe L , Gispert JD , Jessen F , Visser PJ , den Braber A , Ritchie CW , Boada M , Marquié M , Vandenberghe R , Luckett ES , Schöll M , Frisoni GB , Buckley C , Stephens A , Altomare D , Ford L , Birck C , Mett A , Gismondi R , Wolz R , Grootoonk S , Manber R , Shekari M , Lhommel R , Dricot L , Ivanoiu A , Farrar G , Barkhof F , Hanseeuw BJ ,
Alzheimer's research & therapy - Jun 2024
See the complete list of the publications

Videos

Contact

Département de psychiatrie
HUG
Email: Giovanni.Frisoni@hcuge.ch